Financial Gravity Asset Management’s Charles River Laboratories CRL Stock Holding History

Financial Gravity Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$317	–	1218
2023 Q4	$317	Buy	+1	New	+$197	﹤0.01%	973
2021 Q3	$413K	Sell	9 -1	-10%	-$415	0.19%	94
2021 Q2	$370K	Buy	+10	New	+$3.34K	0.13%	106
2020 Q4	$2K	Buy	+10	New	+$2.38K	﹤0.01%	308
2019 Q4	–	Sell	-218	Closed	-$29K	–	1428
2019 Q3	$29K	Buy	218 +13	+6%	+$1.74K	0.03%	385
2019 Q2	$29K	Sell	205 -200	-49%	-$27.1K	0.02%	421
2019 Q1	$59K	Buy	+405	New	+$53.2K	0.05%	276
2018 Q3	$3K	Buy	24 +3	+14%	+$370	﹤0.01%	840
2018 Q2	$3K	Sell	21 -2	-9%	-$216	﹤0.01%	876
2018 Q1	$2K	Buy	+23	New	+$2.48K	﹤0.01%	930

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Financial Gravity Asset Management's CRL Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 1 share — an estimated $317 sold.

Financial Gravity Asset Management first reported a position in CRL in Q1 2018 and held it in 10 quarters. The position peaked at $413K in Q3 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

Financial Gravity Asset Management reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
Financial Gravity Asset Management sold 1 Charles River Laboratories share in Q1 2024, an estimated $317.
Financial Gravity Asset Management first reported a position in Charles River Laboratories in Q1 2018 and held it in 10 quarters.
Financial Gravity Asset Management's Charles River Laboratories position peaked at $413K in Q3 2021.
676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.